This month marks a year since the malaria vaccine rollout began. Here's what we still need in order to beat a disease as old ...

Charting, Price Performance, News & Related Contracts.

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...

Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...

From fixing open gutters to educating kids about the importance of bed nets, a "whole-of-society" approach is needed to ...

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate ...

It said each year, approximately 500,000 people die from malaria, with most of the fatalities occurring among children.

When Rose Akinbiyi’s baby, Jaye, would not eat or stop crying one night, she thought her newborn had a stomach upset.

The World Health Organization (WHO) has approved a diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a genetic condition that can affect malaria treatment.  This test will help ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

Junta restrictions on the delivery of basic medical supplies are leading outbreaks of infectious diseases like tuberculosis, ...

Case reports published in medical literature suggest that tafenoquine combined with standard-of-care treatment exhibits a high cure rate in ...